论文部分内容阅读
《中药新药与临床药理》为中药新药研发、中药临床药理学科重要的学术交流平台,学科影响指标、影响因子以及学科排序在全国同类期刊中位居前列,并全面进入国内重要的核心期刊评价系统,是中国中文核心期刊、中国科技核心期刊、中国科学引文数据库来源期刊(CSCD)、RCCSE中国核心学术期刊,并被WHO西太平洋地区医学索引及美国化学文摘收录,成为中医药行业具有较高学术地位和重要影响力的期刊之一。
The “New Drugs and Clinical Pharmacology of Traditional Chinese Medicine” is an important academic exchange platform for Chinese medicine research and development, and an important academic exchange platform for clinical pharmacology of Chinese medicine. Its influential indexes, influencing factors and discipline rank among the top journals in the country and has entered the important core journals evaluation system in China Is the core Chinese journals, China Science and Technology Journals, China Science Citation Database source journals (CSCD), RCCSE core Chinese academic journals, and was included in the WHO Western Pacific Region Medical Index and the American Chemical Abstracts, as Chinese medicine industry has a high academic Status and one of the most influential journals.